Global Attenuated Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Attenuated Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Attenuated Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attenuated Vaccine that contribute to its increasing demand across many markets.
The global Attenuated Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Attenuated Vaccine total production and demand, 2017-2028, (K Doses)
Global Attenuated Vaccine total production value, 2017-2028, (USD Million)
Global Attenuated Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Doses)
Global Attenuated Vaccine consumption by region & country, CAGR, 2017-2028 & (K Doses)
U.S. VS China: Attenuated Vaccine domestic production, consumption, key domestic manufacturers and share
Global Attenuated Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Doses)
Global Attenuated Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Doses)
Global Attenuated Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Doses)
This reports profiles key players in the global Attenuated Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Attenuated Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Attenuated Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Attenuated Vaccine Market, By Region:
1. How big is the global Attenuated Vaccine market?
2. What is the demand of the global Attenuated Vaccine market?
3. What is the year over year growth of the global Attenuated Vaccine market?
4. What is the production and production value of the global Attenuated Vaccine market?
5. Who are the key producers in the global Attenuated Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Attenuated Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attenuated Vaccine that contribute to its increasing demand across many markets.
The global Attenuated Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Attenuated Vaccine total production and demand, 2017-2028, (K Doses)
Global Attenuated Vaccine total production value, 2017-2028, (USD Million)
Global Attenuated Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Doses)
Global Attenuated Vaccine consumption by region & country, CAGR, 2017-2028 & (K Doses)
U.S. VS China: Attenuated Vaccine domestic production, consumption, key domestic manufacturers and share
Global Attenuated Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Doses)
Global Attenuated Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Doses)
Global Attenuated Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Doses)
This reports profiles key players in the global Attenuated Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Attenuated Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Attenuated Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Attenuated Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Bacterial Vaccine
- Viral Vaccine
- Hospital
- Clinic
- Others
- Merck & Co.
- GlaxoSmithKline plc
- Pfizer Inc
- Sanofi
- Astellas Pharma
- Johnson & Johnson
- CSL Limited
- Serum Institute of India Pvt. Ltd.
- Biken
- Green Cross Corporation
- Shanghai Rongsheng Biotech
- Changchun BCHT Biotechnology Co.,Ltd
1. How big is the global Attenuated Vaccine market?
2. What is the demand of the global Attenuated Vaccine market?
3. What is the year over year growth of the global Attenuated Vaccine market?
4. What is the production and production value of the global Attenuated Vaccine market?
5. Who are the key producers in the global Attenuated Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Attenuated Vaccine Introduction
1.2 World Attenuated Vaccine Supply & Forecast
1.2.1 World Attenuated Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Attenuated Vaccine Production (2017-2028)
1.2.3 World Attenuated Vaccine Pricing Trends (2017-2028)
1.3 World Attenuated Vaccine Production by Region
1.3.1 World Attenuated Vaccine Production Value by Region (2017-2028)
1.3.2 World Attenuated Vaccine Production by Region (2017-2028)
1.3.3 World Attenuated Vaccine Average Price by Region (2017-2028)
1.3.4 North America Attenuated Vaccine Production (2017-2028)
1.3.5 Europe Attenuated Vaccine Production (2017-2028)
1.3.6 China Attenuated Vaccine Production (2017-2028)
1.3.7 Japan Attenuated Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Attenuated Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Attenuated Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Attenuated Vaccine Demand (2017-2028)
2.2 World Attenuated Vaccine Consumption by Region
2.2.1 World Attenuated Vaccine Consumption by Region (2017-2022)
2.2.2 World Attenuated Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Attenuated Vaccine Consumption (2017-2028)
2.4 China Attenuated Vaccine Consumption (2017-2028)
2.5 Europe Attenuated Vaccine Consumption (2017-2028)
2.6 Japan Attenuated Vaccine Consumption (2017-2028)
2.7 South Korea Attenuated Vaccine Consumption (2017-2028)
2.8 ASEAN Attenuated Vaccine Consumption (2017-2028)
2.9 India Attenuated Vaccine Consumption (2017-2028)
3 WORLD ATTENUATED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Attenuated Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Attenuated Vaccine Production by Manufacturer (2017-2022)
3.3 World Attenuated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Attenuated Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Attenuated Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Attenuated Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Attenuated Vaccine in 2021
3.6 Attenuated Vaccine Market: Overall Company Footprint Analysis
3.6.1 Attenuated Vaccine Market: Region Footprint
3.6.2 Attenuated Vaccine Market: Company Product Type Footprint
3.6.3 Attenuated Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Attenuated Vaccine Production Value Comparison
4.1.1 United States VS China: Attenuated Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Attenuated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Attenuated Vaccine Production Comparison
4.2.1 United States VS China: Attenuated Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Attenuated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Attenuated Vaccine Consumption Comparison
4.3.1 United States VS China: Attenuated Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Attenuated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Attenuated Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Attenuated Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Attenuated Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Attenuated Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Attenuated Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Attenuated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Attenuated Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Bacterial Vaccine
5.2.2 Viral Vaccine
5.3 Market Segment by Type
5.3.1 World Attenuated Vaccine Production by Type (2017-2028)
5.3.2 World Attenuated Vaccine Production Value by Type (2017-2028)
5.3.3 World Attenuated Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Attenuated Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Attenuated Vaccine Production by Application (2017-2028)
6.3.2 World Attenuated Vaccine Production Value by Application (2017-2028)
6.3.3 World Attenuated Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck & Co.
7.1.1 Merck & Co. Details
7.1.2 Merck & Co. Major Business
7.1.3 Merck & Co. Attenuated Vaccine Product and Services
7.1.4 Merck & Co. Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck & Co. Recent Developments/Updates
7.1.6 Merck & Co. Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Details
7.2.2 GlaxoSmithKline plc Major Business
7.2.3 GlaxoSmithKline plc Attenuated Vaccine Product and Services
7.2.4 GlaxoSmithKline plc Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GlaxoSmithKline plc Recent Developments/Updates
7.2.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Attenuated Vaccine Product and Services
7.3.4 Pfizer Inc Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Attenuated Vaccine Product and Services
7.4.4 Sanofi Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Astellas Pharma
7.5.1 Astellas Pharma Details
7.5.2 Astellas Pharma Major Business
7.5.3 Astellas Pharma Attenuated Vaccine Product and Services
7.5.4 Astellas Pharma Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Astellas Pharma Recent Developments/Updates
7.5.6 Astellas Pharma Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Attenuated Vaccine Product and Services
7.6.4 Johnson & Johnson Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 CSL Limited
7.7.1 CSL Limited Details
7.7.2 CSL Limited Major Business
7.7.3 CSL Limited Attenuated Vaccine Product and Services
7.7.4 CSL Limited Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 CSL Limited Recent Developments/Updates
7.7.6 CSL Limited Competitive Strengths & Weaknesses
7.8 Serum Institute of India Pvt. Ltd.
7.8.1 Serum Institute of India Pvt. Ltd. Details
7.8.2 Serum Institute of India Pvt. Ltd. Major Business
7.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
7.8.4 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
7.8.6 Serum Institute of India Pvt. Ltd. Competitive Strengths & Weaknesses
7.9 Biken
7.9.1 Biken Details
7.9.2 Biken Major Business
7.9.3 Biken Attenuated Vaccine Product and Services
7.9.4 Biken Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Biken Recent Developments/Updates
7.9.6 Biken Competitive Strengths & Weaknesses
7.10 Green Cross Corporation
7.10.1 Green Cross Corporation Details
7.10.2 Green Cross Corporation Major Business
7.10.3 Green Cross Corporation Attenuated Vaccine Product and Services
7.10.4 Green Cross Corporation Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Green Cross Corporation Recent Developments/Updates
7.10.6 Green Cross Corporation Competitive Strengths & Weaknesses
7.11 Shanghai Rongsheng Biotech
7.11.1 Shanghai Rongsheng Biotech Details
7.11.2 Shanghai Rongsheng Biotech Major Business
7.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
7.11.4 Shanghai Rongsheng Biotech Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shanghai Rongsheng Biotech Recent Developments/Updates
7.11.6 Shanghai Rongsheng Biotech Competitive Strengths & Weaknesses
7.12 Changchun BCHT Biotechnology Co.,Ltd
7.12.1 Changchun BCHT Biotechnology Co.,Ltd Details
7.12.2 Changchun BCHT Biotechnology Co.,Ltd Major Business
7.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
7.12.4 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Developments/Updates
7.12.6 Changchun BCHT Biotechnology Co.,Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Attenuated Vaccine and Key Manufacturers
8.2 Attenuated Vaccine Manufacturing Costs
8.3 Attenuated Vaccine Production Process
8.4 Attenuated Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Attenuated Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Attenuated Vaccine Typical Distributors
9.3 Attenuated Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Attenuated Vaccine Introduction
1.2 World Attenuated Vaccine Supply & Forecast
1.2.1 World Attenuated Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Attenuated Vaccine Production (2017-2028)
1.2.3 World Attenuated Vaccine Pricing Trends (2017-2028)
1.3 World Attenuated Vaccine Production by Region
1.3.1 World Attenuated Vaccine Production Value by Region (2017-2028)
1.3.2 World Attenuated Vaccine Production by Region (2017-2028)
1.3.3 World Attenuated Vaccine Average Price by Region (2017-2028)
1.3.4 North America Attenuated Vaccine Production (2017-2028)
1.3.5 Europe Attenuated Vaccine Production (2017-2028)
1.3.6 China Attenuated Vaccine Production (2017-2028)
1.3.7 Japan Attenuated Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Attenuated Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Attenuated Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Attenuated Vaccine Demand (2017-2028)
2.2 World Attenuated Vaccine Consumption by Region
2.2.1 World Attenuated Vaccine Consumption by Region (2017-2022)
2.2.2 World Attenuated Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Attenuated Vaccine Consumption (2017-2028)
2.4 China Attenuated Vaccine Consumption (2017-2028)
2.5 Europe Attenuated Vaccine Consumption (2017-2028)
2.6 Japan Attenuated Vaccine Consumption (2017-2028)
2.7 South Korea Attenuated Vaccine Consumption (2017-2028)
2.8 ASEAN Attenuated Vaccine Consumption (2017-2028)
2.9 India Attenuated Vaccine Consumption (2017-2028)
3 WORLD ATTENUATED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Attenuated Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Attenuated Vaccine Production by Manufacturer (2017-2022)
3.3 World Attenuated Vaccine Average Price by Manufacturer (2017-2022)
3.4 Attenuated Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Attenuated Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Attenuated Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Attenuated Vaccine in 2021
3.6 Attenuated Vaccine Market: Overall Company Footprint Analysis
3.6.1 Attenuated Vaccine Market: Region Footprint
3.6.2 Attenuated Vaccine Market: Company Product Type Footprint
3.6.3 Attenuated Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Attenuated Vaccine Production Value Comparison
4.1.1 United States VS China: Attenuated Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Attenuated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Attenuated Vaccine Production Comparison
4.2.1 United States VS China: Attenuated Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Attenuated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Attenuated Vaccine Consumption Comparison
4.3.1 United States VS China: Attenuated Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Attenuated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Attenuated Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Attenuated Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Attenuated Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Attenuated Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Attenuated Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Attenuated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Attenuated Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Bacterial Vaccine
5.2.2 Viral Vaccine
5.3 Market Segment by Type
5.3.1 World Attenuated Vaccine Production by Type (2017-2028)
5.3.2 World Attenuated Vaccine Production Value by Type (2017-2028)
5.3.3 World Attenuated Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Attenuated Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Attenuated Vaccine Production by Application (2017-2028)
6.3.2 World Attenuated Vaccine Production Value by Application (2017-2028)
6.3.3 World Attenuated Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Merck & Co.
7.1.1 Merck & Co. Details
7.1.2 Merck & Co. Major Business
7.1.3 Merck & Co. Attenuated Vaccine Product and Services
7.1.4 Merck & Co. Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Merck & Co. Recent Developments/Updates
7.1.6 Merck & Co. Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Details
7.2.2 GlaxoSmithKline plc Major Business
7.2.3 GlaxoSmithKline plc Attenuated Vaccine Product and Services
7.2.4 GlaxoSmithKline plc Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GlaxoSmithKline plc Recent Developments/Updates
7.2.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Attenuated Vaccine Product and Services
7.3.4 Pfizer Inc Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Attenuated Vaccine Product and Services
7.4.4 Sanofi Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Astellas Pharma
7.5.1 Astellas Pharma Details
7.5.2 Astellas Pharma Major Business
7.5.3 Astellas Pharma Attenuated Vaccine Product and Services
7.5.4 Astellas Pharma Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Astellas Pharma Recent Developments/Updates
7.5.6 Astellas Pharma Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Attenuated Vaccine Product and Services
7.6.4 Johnson & Johnson Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 CSL Limited
7.7.1 CSL Limited Details
7.7.2 CSL Limited Major Business
7.7.3 CSL Limited Attenuated Vaccine Product and Services
7.7.4 CSL Limited Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 CSL Limited Recent Developments/Updates
7.7.6 CSL Limited Competitive Strengths & Weaknesses
7.8 Serum Institute of India Pvt. Ltd.
7.8.1 Serum Institute of India Pvt. Ltd. Details
7.8.2 Serum Institute of India Pvt. Ltd. Major Business
7.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
7.8.4 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
7.8.6 Serum Institute of India Pvt. Ltd. Competitive Strengths & Weaknesses
7.9 Biken
7.9.1 Biken Details
7.9.2 Biken Major Business
7.9.3 Biken Attenuated Vaccine Product and Services
7.9.4 Biken Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Biken Recent Developments/Updates
7.9.6 Biken Competitive Strengths & Weaknesses
7.10 Green Cross Corporation
7.10.1 Green Cross Corporation Details
7.10.2 Green Cross Corporation Major Business
7.10.3 Green Cross Corporation Attenuated Vaccine Product and Services
7.10.4 Green Cross Corporation Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Green Cross Corporation Recent Developments/Updates
7.10.6 Green Cross Corporation Competitive Strengths & Weaknesses
7.11 Shanghai Rongsheng Biotech
7.11.1 Shanghai Rongsheng Biotech Details
7.11.2 Shanghai Rongsheng Biotech Major Business
7.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
7.11.4 Shanghai Rongsheng Biotech Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shanghai Rongsheng Biotech Recent Developments/Updates
7.11.6 Shanghai Rongsheng Biotech Competitive Strengths & Weaknesses
7.12 Changchun BCHT Biotechnology Co.,Ltd
7.12.1 Changchun BCHT Biotechnology Co.,Ltd Details
7.12.2 Changchun BCHT Biotechnology Co.,Ltd Major Business
7.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
7.12.4 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Developments/Updates
7.12.6 Changchun BCHT Biotechnology Co.,Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Attenuated Vaccine and Key Manufacturers
8.2 Attenuated Vaccine Manufacturing Costs
8.3 Attenuated Vaccine Production Process
8.4 Attenuated Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Attenuated Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Attenuated Vaccine Typical Distributors
9.3 Attenuated Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Attenuated Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Attenuated Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Attenuated Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Attenuated Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Attenuated Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Attenuated Vaccine Production by Region (2017-2022) & (K Doses)
Table 7. World Attenuated Vaccine Production by Region (2023-2028) & (K Doses)
Table 8. World Attenuated Vaccine Production Market Share by Region (2017-2022)
Table 9. World Attenuated Vaccine Production Market Share by Region (2023-2028)
Table 10. World Attenuated Vaccine Average Price by Region (2017-2022) & (US$/Dose)
Table 11. World Attenuated Vaccine Average Price by Region (2023-2028) & (US$/Dose)
Table 12. Attenuated Vaccine Major Market Trends
Table 13. World Attenuated Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Doses)
Table 14. World Attenuated Vaccine Consumption by Region (2017-2022) & (K Doses)
Table 15. World Attenuated Vaccine Consumption Forecast by Region (2023-2028) & (K Doses)
Table 16. World Attenuated Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Attenuated Vaccine Producers in 2021
Table 18. World Attenuated Vaccine Production by Manufacturer (2017-2022) & (K Doses)
Table 19. Production Market Share of Key Attenuated Vaccine Producers in 2021
Table 20. World Attenuated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Dose)
Table 21. Global Attenuated Vaccine Company Evaluation Quadrant
Table 22. World Attenuated Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Attenuated Vaccine Production Site of Key Manufacturer
Table 24. Attenuated Vaccine Market: Company Product Type Footprint
Table 25. Attenuated Vaccine Market: Company Product Application Footprint
Table 26. Attenuated Vaccine Competitive Factors
Table 27. Attenuated Vaccine New Entrant and Capacity Expansion Plans
Table 28. Attenuated Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Attenuated Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Attenuated Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Doses)
Table 31. United States VS China Attenuated Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Doses)
Table 32. Major Manufacturer of Attenuated Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Attenuated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Doses)
Table 36. United States Attenuated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Attenuated Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Attenuated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Doses)
Table 41. China Attenuated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Attenuated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Attenuated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Doses)
Table 46. Rest of World Attenuated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Attenuated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Attenuated Vaccine Production by Type (2017-2022) & (K Doses)
Table 49. World Attenuated Vaccine Production by Type (2023-2028) & (K Doses)
Table 50. World Attenuated Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Attenuated Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Attenuated Vaccine Average Price by Type (2017-2022) & (US$/Dose)
Table 53. World Attenuated Vaccine Average Price by Type (2023-2028) & (US$/Dose)
Table 54. World Attenuated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Attenuated Vaccine Production by Application (2017-2022) & (K Doses)
Table 56. World Attenuated Vaccine Production by Application (2023-2028) & (K Doses)
Table 57. World Attenuated Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Attenuated Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Attenuated Vaccine Average Price by Application (2017-2022) & (US$/Dose)
Table 60. World Attenuated Vaccine Average Price by Application (2023-2028) & (US$/Dose)
Table 61. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co. Major Business
Table 63. Merck & Co. Attenuated Vaccine Product and Services
Table 64. Merck & Co. Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck & Co. Recent Developments/Updates
Table 66. Merck & Co. Competitive Strengths & Weaknesses
Table 67. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline plc Major Business
Table 69. GlaxoSmithKline plc Attenuated Vaccine Product and Services
Table 70. GlaxoSmithKline plc Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GlaxoSmithKline plc Recent Developments/Updates
Table 72. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 73. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc Major Business
Table 75. Pfizer Inc Attenuated Vaccine Product and Services
Table 76. Pfizer Inc Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Pfizer Inc Recent Developments/Updates
Table 78. Pfizer Inc Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Attenuated Vaccine Product and Services
Table 82. Sanofi Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Astellas Pharma Major Business
Table 87. Astellas Pharma Attenuated Vaccine Product and Services
Table 88. Astellas Pharma Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Astellas Pharma Recent Developments/Updates
Table 90. Astellas Pharma Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Attenuated Vaccine Product and Services
Table 94. Johnson & Johnson Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 98. CSL Limited Major Business
Table 99. CSL Limited Attenuated Vaccine Product and Services
Table 100. CSL Limited Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. CSL Limited Recent Developments/Updates
Table 102. CSL Limited Competitive Strengths & Weaknesses
Table 103. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Serum Institute of India Pvt. Ltd. Major Business
Table 105. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
Table 106. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 108. Serum Institute of India Pvt. Ltd. Competitive Strengths & Weaknesses
Table 109. Biken Basic Information, Manufacturing Base and Competitors
Table 110. Biken Major Business
Table 111. Biken Attenuated Vaccine Product and Services
Table 112. Biken Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Biken Recent Developments/Updates
Table 114. Biken Competitive Strengths & Weaknesses
Table 115. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 116. Green Cross Corporation Major Business
Table 117. Green Cross Corporation Attenuated Vaccine Product and Services
Table 118. Green Cross Corporation Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Green Cross Corporation Recent Developments/Updates
Table 120. Green Cross Corporation Competitive Strengths & Weaknesses
Table 121. Shanghai Rongsheng Biotech Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Rongsheng Biotech Major Business
Table 123. Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
Table 124. Shanghai Rongsheng Biotech Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shanghai Rongsheng Biotech Recent Developments/Updates
Table 126. Changchun BCHT Biotechnology Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 127. Changchun BCHT Biotechnology Co.,Ltd Major Business
Table 128. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
Table 129. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Attenuated Vaccine Raw Material
Table 131. Key Manufacturers of Attenuated Vaccine Raw Materials
Table 132. Attenuated Vaccine Typical Distributors
Table 133. Attenuated Vaccine Typical Customers
Table 1. World Attenuated Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Attenuated Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Attenuated Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Attenuated Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Attenuated Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Attenuated Vaccine Production by Region (2017-2022) & (K Doses)
Table 7. World Attenuated Vaccine Production by Region (2023-2028) & (K Doses)
Table 8. World Attenuated Vaccine Production Market Share by Region (2017-2022)
Table 9. World Attenuated Vaccine Production Market Share by Region (2023-2028)
Table 10. World Attenuated Vaccine Average Price by Region (2017-2022) & (US$/Dose)
Table 11. World Attenuated Vaccine Average Price by Region (2023-2028) & (US$/Dose)
Table 12. Attenuated Vaccine Major Market Trends
Table 13. World Attenuated Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Doses)
Table 14. World Attenuated Vaccine Consumption by Region (2017-2022) & (K Doses)
Table 15. World Attenuated Vaccine Consumption Forecast by Region (2023-2028) & (K Doses)
Table 16. World Attenuated Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Attenuated Vaccine Producers in 2021
Table 18. World Attenuated Vaccine Production by Manufacturer (2017-2022) & (K Doses)
Table 19. Production Market Share of Key Attenuated Vaccine Producers in 2021
Table 20. World Attenuated Vaccine Average Price by Manufacturer (2017-2022) & (US$/Dose)
Table 21. Global Attenuated Vaccine Company Evaluation Quadrant
Table 22. World Attenuated Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Attenuated Vaccine Production Site of Key Manufacturer
Table 24. Attenuated Vaccine Market: Company Product Type Footprint
Table 25. Attenuated Vaccine Market: Company Product Application Footprint
Table 26. Attenuated Vaccine Competitive Factors
Table 27. Attenuated Vaccine New Entrant and Capacity Expansion Plans
Table 28. Attenuated Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Attenuated Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Attenuated Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Doses)
Table 31. United States VS China Attenuated Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Doses)
Table 32. Major Manufacturer of Attenuated Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Attenuated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Doses)
Table 36. United States Attenuated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Attenuated Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Attenuated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Doses)
Table 41. China Attenuated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Attenuated Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Attenuated Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Attenuated Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Attenuated Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Doses)
Table 46. Rest of World Attenuated Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Attenuated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Attenuated Vaccine Production by Type (2017-2022) & (K Doses)
Table 49. World Attenuated Vaccine Production by Type (2023-2028) & (K Doses)
Table 50. World Attenuated Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Attenuated Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Attenuated Vaccine Average Price by Type (2017-2022) & (US$/Dose)
Table 53. World Attenuated Vaccine Average Price by Type (2023-2028) & (US$/Dose)
Table 54. World Attenuated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Attenuated Vaccine Production by Application (2017-2022) & (K Doses)
Table 56. World Attenuated Vaccine Production by Application (2023-2028) & (K Doses)
Table 57. World Attenuated Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Attenuated Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Attenuated Vaccine Average Price by Application (2017-2022) & (US$/Dose)
Table 60. World Attenuated Vaccine Average Price by Application (2023-2028) & (US$/Dose)
Table 61. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co. Major Business
Table 63. Merck & Co. Attenuated Vaccine Product and Services
Table 64. Merck & Co. Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Merck & Co. Recent Developments/Updates
Table 66. Merck & Co. Competitive Strengths & Weaknesses
Table 67. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline plc Major Business
Table 69. GlaxoSmithKline plc Attenuated Vaccine Product and Services
Table 70. GlaxoSmithKline plc Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GlaxoSmithKline plc Recent Developments/Updates
Table 72. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 73. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Inc Major Business
Table 75. Pfizer Inc Attenuated Vaccine Product and Services
Table 76. Pfizer Inc Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Pfizer Inc Recent Developments/Updates
Table 78. Pfizer Inc Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Attenuated Vaccine Product and Services
Table 82. Sanofi Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Astellas Pharma Major Business
Table 87. Astellas Pharma Attenuated Vaccine Product and Services
Table 88. Astellas Pharma Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Astellas Pharma Recent Developments/Updates
Table 90. Astellas Pharma Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Attenuated Vaccine Product and Services
Table 94. Johnson & Johnson Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 98. CSL Limited Major Business
Table 99. CSL Limited Attenuated Vaccine Product and Services
Table 100. CSL Limited Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. CSL Limited Recent Developments/Updates
Table 102. CSL Limited Competitive Strengths & Weaknesses
Table 103. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Serum Institute of India Pvt. Ltd. Major Business
Table 105. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product and Services
Table 106. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 108. Serum Institute of India Pvt. Ltd. Competitive Strengths & Weaknesses
Table 109. Biken Basic Information, Manufacturing Base and Competitors
Table 110. Biken Major Business
Table 111. Biken Attenuated Vaccine Product and Services
Table 112. Biken Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Biken Recent Developments/Updates
Table 114. Biken Competitive Strengths & Weaknesses
Table 115. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 116. Green Cross Corporation Major Business
Table 117. Green Cross Corporation Attenuated Vaccine Product and Services
Table 118. Green Cross Corporation Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Green Cross Corporation Recent Developments/Updates
Table 120. Green Cross Corporation Competitive Strengths & Weaknesses
Table 121. Shanghai Rongsheng Biotech Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Rongsheng Biotech Major Business
Table 123. Shanghai Rongsheng Biotech Attenuated Vaccine Product and Services
Table 124. Shanghai Rongsheng Biotech Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shanghai Rongsheng Biotech Recent Developments/Updates
Table 126. Changchun BCHT Biotechnology Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 127. Changchun BCHT Biotechnology Co.,Ltd Major Business
Table 128. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product and Services
Table 129. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Production (K Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Attenuated Vaccine Raw Material
Table 131. Key Manufacturers of Attenuated Vaccine Raw Materials
Table 132. Attenuated Vaccine Typical Distributors
Table 133. Attenuated Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Attenuated Vaccine Picture
Figure 2. World Attenuated Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Attenuated Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 5. World Attenuated Vaccine Average Price (2017-2028) & (US$/Dose)
Figure 6. World Attenuated Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Attenuated Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 9. Europe Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 10. China Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 11. Japan Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 12. Attenuated Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Attenuated Vaccine Demand (2017-2028) & (K Doses)
Figure 15. World Attenuated Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 17. China Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 18. Europe Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 19. Japan Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 20. South Korea Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 21. ASEAN Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 22. India Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 23. Producer Shipments of Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Attenuated Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Attenuated Vaccine Markets in 2021
Figure 26. United States VS China: Attenuated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Attenuated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Attenuated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Attenuated Vaccine in United States
Figure 30. Key Producers and Market Share of Attenuated Vaccine in China
Figure 31. Key Producers and Market Share of Attenuated Vaccine in Rest of World
Figure 32. World Attenuated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Attenuated Vaccine Production Value Market Share by Type in 2021
Figure 34. Bacterial Vaccine
Figure 35. Viral Vaccine
Figure 36. World Attenuated Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Attenuated Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Attenuated Vaccine Average Price by Type (2017-2028) & (US$/Dose)
Figure 39. World Attenuated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Attenuated Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Attenuated Vaccine Production Market Share by Application (2017-2028)
Figure 45. World Attenuated Vaccine Production Value Market Share by Application (2017-2028)
Figure 46. World Attenuated Vaccine Average Price by Application (2017-2028) & (US$/Dose)
Figure 47. Manufacturing Cost Structure Analysis of Attenuated Vaccine in 2021
Figure 48. Manufacturing Process Analysis of Attenuated Vaccine
Figure 49. Attenuated Vaccine Industrial Chain
Figure 50. Distribution Channel Breakdown for Attenuated Vaccine Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Attenuated Vaccine Picture
Figure 2. World Attenuated Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Attenuated Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 5. World Attenuated Vaccine Average Price (2017-2028) & (US$/Dose)
Figure 6. World Attenuated Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Attenuated Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 9. Europe Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 10. China Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 11. Japan Attenuated Vaccine Production (2017-2028) & (K Doses)
Figure 12. Attenuated Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Attenuated Vaccine Demand (2017-2028) & (K Doses)
Figure 15. World Attenuated Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 17. China Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 18. Europe Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 19. Japan Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 20. South Korea Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 21. ASEAN Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 22. India Attenuated Vaccine Consumption (2017-2028) & (K Doses)
Figure 23. Producer Shipments of Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Attenuated Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Attenuated Vaccine Markets in 2021
Figure 26. United States VS China: Attenuated Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Attenuated Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Attenuated Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Attenuated Vaccine in United States
Figure 30. Key Producers and Market Share of Attenuated Vaccine in China
Figure 31. Key Producers and Market Share of Attenuated Vaccine in Rest of World
Figure 32. World Attenuated Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Attenuated Vaccine Production Value Market Share by Type in 2021
Figure 34. Bacterial Vaccine
Figure 35. Viral Vaccine
Figure 36. World Attenuated Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Attenuated Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Attenuated Vaccine Average Price by Type (2017-2028) & (US$/Dose)
Figure 39. World Attenuated Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Attenuated Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Attenuated Vaccine Production Market Share by Application (2017-2028)
Figure 45. World Attenuated Vaccine Production Value Market Share by Application (2017-2028)
Figure 46. World Attenuated Vaccine Average Price by Application (2017-2028) & (US$/Dose)
Figure 47. Manufacturing Cost Structure Analysis of Attenuated Vaccine in 2021
Figure 48. Manufacturing Process Analysis of Attenuated Vaccine
Figure 49. Attenuated Vaccine Industrial Chain
Figure 50. Distribution Channel Breakdown for Attenuated Vaccine Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
